Evidence map›Paper›PMID 22983008›Full record

ArticleCell cycle (Georgetown, Tex.)2012

The transcription factor CREBZF is a novel positive regulator of p53.

Irene López-Mateo, M Ángeles Villaronga, Susana Llanos, Borja Belandia

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Emerging Role of SMILE in Liver Metabolism.International journal of molecular sciences · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Antineoplastic Effects of Ankaferd Hemostat.BioMed research international · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Irene López-MateoDepartment of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, Madrid, Spain.
M Ángeles Villaronga
Susana Llanos
Borja Belandia
Instituto de Investigaciones Biomédicas Sols-Morreale · ESInstituto de Investigación Sanitaria del Principado de Asturias · ESSpanish National Cancer Research Centre · ESUniversidad Autónoma de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CREBZF is a member of the mammalian ATF/CREB family of transcription factors. Here, we describe a novel functional interaction between CREBZF and the tumor suppressor p53. CREBZF was identified in a yeast two-hybrid screen using HEY1, recently characterized as an indirect p53 activator, as bait. CREBZF interacts in vitro with both HEY1 and p53, and CREBZF expression stabilizes and activates p53. Moreover, CREBZF cooperates synergistically with HEY1 to enhance p53 transcriptional activity. On the other hand, partial depletion of endogenous CREBZF diminishes p53 protein levels and inhibits HEY1-mediated activation of p53. CREBZF-positive effects on p53 signaling may reflect, at least in part, an observed induction of posttranslational modifications in p53 known to prevent its degradation. CREBZF expression protects HCT116 cells from UV radiation-induced cell death. In addition, CREBZF expression confers sensitivity to 5-fluorouracil, a p53-activating chemotherapeutic drug. Our study suggests that CREBZF may participate in the modulation of p53 tumor suppressor function.

Indexed as

Gene Expression RegulationTranscription, GeneticAnimalsAntimetabolites, AntineoplasticBasic Helix-Loop-Helix ProteinsBasic-Leucine Zipper Transcription FactorsCell DeathCell Line, TumorChlorocebus aethiopsCOS CellsFluorouracilGenes, ReporterHumansLuciferasesPlasmidsProtein BindingAntimetabolites, AntineoplasticBasic Helix-Loop-Helix ProteinsBasic-Leucine Zipper Transcription FactorsCREBZF protein, humanFluorouracilHairy, HRT1 proteinLuciferasesRecombinant Fusion ProteinsRepressor ProteinsTumor Suppressor Protein p53

Identifiers

PMID22983008
PMCPMC3495830
OpenAlexW2001670989

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.